ID   K209
AC   CVCL_W340
SY   A549 (K209)
DR   cancercelllines; CVCL_W340
DR   Wikidata; Q54899270
RX   PubMed=11991756;
CC   Group: Adeno-associated virus packaging cell line.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 12
//
RX   PubMed=11991756; DOI=10.1006/mthe.2001.0591;
RA   Gao G.-P., Lu F.-M., Sanmiguel J.C., Tran P.T., Abbas Z., Lynd K.S.,
RA   Marsh J., Spinner N.B., Wilson J.M.;
RT   "Rep/Cap gene amplification and high-yield production of AAV in an
RT   A549 cell line expressing Rep/Cap.";
RL   Mol. Ther. 5:644-649(2002).
//